Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors.
Eva MeixnerNathalie AriansNina BougatfLine HoeltgenLaila KönigKristin LangChristoph DomschkeMarkus WallwienerJonathan W LischalkFelix K F KommossJürgen DebusJuliane Hörner-RieberPublished in: Tumori (2021)
In treatment of vaginal cancer, high-dose RT in combination with brachytherapy is well tolerated and results in effective local control rates, which significantly improve with an EQD2(α/β=10) ⩾65 Gy. Multivariate analyses revealed concomitant chemotherapy was a positive prognostic factor for overall and progression-free survival.
Keyphrases
- prognostic factors
- high dose
- locally advanced
- papillary thyroid
- free survival
- rectal cancer
- radiation therapy
- squamous cell
- low dose
- early stage
- stem cell transplantation
- prostate cancer
- type diabetes
- lymph node metastasis
- radiation induced
- metabolic syndrome
- single cell
- young adults
- radical prostatectomy
- data analysis
- chemotherapy induced